first-line anti-tubercular drug resistance of mycobacterium tuberculosis in iran: a systematic review
Clicks: 252
ID: 254722
2016
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.0
/100
252 views
61 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #572 of 875 articles by views in journal of magnetic resonance (san diego, calif : 1997)
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 875 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Background: The spread of drug-resistant tuberculosis (TB) is one of the major public health problems in the world. Surveillance of anti-TB drug resistance is important for monitoring of TB control strategies. The occurrence of drug resistance, particularly multi-drug resistance Mycobacterium tuberculosis (MDR), defined as resistance to at least rifampicin (RIF) and isoniazid (INH), has become a significant public health dilemma. However, the status of drug-resistance TB in Iran has been reported inconsistently. Therefore, the aim of this study was to summarize reports on first-line anti-tubercular drug resistance of M. tuberculosis in Iran.Material and Methods: We systematically reviewed published studies on drug-resistant M. tuberculosis in Iran. Search terms ̎Mycobacterium tuberculosis susceptibility ̎ and ̎Mycobacterium tuberculosis resistant ̎ were used in PubMed, Google Scholar, Magiran, IrMedex and SID. Results: Fifty- two eligible articles, published during 1998-2014, were included in this review. Most studies were conducted in Tehran. The most common laboratory method was used for anti-drug resistant of M. tuberculosis was Agar proportion. The average prevalence of resistant against INH in Tehran was 26%, RIF 23%, streptomycin (SM) 22.5% and ethambotol (EMB) 16% by Agar proportion method. In general, resistance to INH was more common than RIF, SM and EMB in Tehran. The average prevalence of resistant against INH in Tabriz was 15%, RIF 5%, SM 19% and EMB 2% by proportion. The highest resistance to first-line drugs was seen in Tehran.Conclusions: In conclusion, this systematic review summarized the prevalence and distribution of first-line anti-tubercular drug resistance of M. tuberculosis in Iran. Our results suggested that effective strategies to minimize the acquired drug resistance, to control the transmission of resistance and improve the diagnosis measures for TB control in Iran.
| Reference Key |
pourakbari2016frontiersfirst-line
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Babak Pourakbari;Setareh Mamishi;Mona Mohammadzadeh;Shima Mahmoudi |
| Journal | journal of magnetic resonance (san diego, calif : 1997) |
| Year | 2016 |
| DOI |
10.3389/fmicb.2016.01139
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.